Insulin giant Novo Nordisk (NYSE:NVO) has reportedly approached Global Blood Therapeutics (NSDQ:GBT) to discuss a possible takeover.
The U.S. biotech is reviewing its options with an investment bank, according to Reuters, and there is no guarantee that it will enter formal negotiations with Novo Nordisk.
Get the full story at our sister site, Drug Delivery Business News.
The post Novo Nordisk approaches Global Blood Therapeutics for possible takeover appeared first on MassDevice.
